What Companies Are Attending J.P. Morgan Healthcare Conference 2027?

Quick Answer

Companies with announced participation in the J.P. Morgan Healthcare Conference 2027 include Immix Biopharma, Gubra, Genomics plc, Vicore Pharma, and Owkin. These companies specialize in biotechnology, pharmaceutical research, genetic medicine, and AI-driven drug discovery.

Other companies participating in JPM Week 2027 partnering events include Johnson & Johnson, Samsung Biologics, Arcutis Biotherapeutics, Circle Pharma, Eledon Pharmaceuticals, and MedinCell. These events bring together healthcare companies, investors, and business development teams exploring funding, licensing, and strategic partnerships.

J.P. Morgan Healthcare Conference 2027 at a Glance

Companies Participating in J.P. Morgan Healthcare Conference 2027

These companies have published 2027 conference announcements, corporate event calendar listings, or meeting programs.

Additional Companies Participating in BIO Partnering @ JPM Week 2027

BIO Partnering @ JPM Week connects biotechnology companies, investors, and industry partners through a separately organized meeting program.

The following companies appear in the 2027 BIO Partnering participating-company directory.

Other Organizations Active During JPM Week 2027

These organizations have announced meetings, networking programs, or other activities during JPM Week in San Francisco.

Company Profiles

Companies With Announced 2027 Conference Participation

Immix Biopharma

Immix Biopharma is a biotechnology company developing cell therapies for serious diseases, including AL amyloidosis. On October 5, 2026, the company announced that it will present at the 45th Annual J.P. Morgan Healthcare Conference, where its clinical development activities and NXC-201 therapy program are relevant to investors and industry partners.

Gubra

Gubra is a Denmark-based biotechnology company developing peptide therapeutics and preclinical research solutions, particularly for metabolic diseases. Its corporate investor calendar confirms participation in the J.P. Morgan Healthcare Conference 2027 in San Francisco.

Genomics plc

Genomics plc develops genetic risk prediction technology and research capabilities using human genetics and AI. The company has listed the January 2027 J.P. Morgan Healthcare Conference on its events calendar and is connecting with industry partners around precision medicine and drug discovery applications.

Vicore Pharma

Vicore Pharma is a Swedish clinical-stage pharmaceutical company developing treatments for rare respiratory diseases, including idiopathic pulmonary fibrosis. Its investor relations calendar lists the J.P. Morgan Healthcare Conference 2027, alongside ongoing clinical development activity involving its lead candidate buloxibutid.

Owkin

Owkin is an AI biotechnology company applying machine learning and multimodal biological data to drug discovery and development. Its 2027 conference program includes partnership meetings covering Owkin K Pro, biological data networks, and the MOSAIC research initiative.

Biotechnology and Pharmaceutical Companies Participating in JPM Week 2027

Johnson & Johnson

Johnson & Johnson is a global healthcare company developing pharmaceuticals and medical technologies. Its businesses span oncology, immunology, neuroscience, cardiovascular technology, and surgery, with continued investment in research, product development, and healthcare partnerships.

Samsung Biologics

Samsung Biologics is a biopharmaceutical contract development and manufacturing organization providing manufacturing and development services to pharmaceutical companies. Its capabilities support biologic medicines across drug development, manufacturing, and commercial supply.

Arcutis Biotherapeutics

Arcutis Biotherapeutics develops medicines for inflammatory skin diseases, including psoriasis and atopic dermatitis. Its commercial portfolio includes ZORYVE, alongside clinical research programs targeting additional dermatological conditions.

Circle Pharma

Circle Pharma is a clinical-stage biopharmaceutical company developing targeted cancer medicines using macrocyclic therapeutics. Its research focuses on difficult-to-target proteins involved in cancer, including cyclins that regulate cell growth.

Affinia Therapeutics

Affinia Therapeutics develops gene therapies using engineered adeno-associated viral vectors. Its technology platform focuses on improving the delivery, safety, and manufacturing of genetic medicines for diseases with significant unmet medical needs.

Eledon Pharmaceuticals

Eledon Pharmaceuticals is a biotechnology company developing immunomodulatory treatments with applications in transplantation and immune-mediated diseases. Its research focuses on therapies that could improve outcomes for patients receiving organ transplants.

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology company developing cancer medicines using biomarker-based patient selection. Its approach combines drug development with technologies designed to identify patients most likely to benefit from specific treatments.

Kyowa Kirin

Kyowa Kirin is a global pharmaceutical company focused on specialty medicines and innovative therapies. Its research and commercial activities cover rare diseases, immunology, hematology, and other areas requiring specialized medical treatments.

Eisai

Eisai is a Japanese pharmaceutical company developing medicines across neurology, oncology, and other therapeutic areas. Its drug development portfolio includes research into Alzheimer's disease, cancer therapies, and treatments addressing significant unmet medical needs.

Grifols

Grifols is a global healthcare company specializing in plasma-derived medicines, diagnostic technology, and biopharmaceutical products. Its manufacturing and research activities support therapies for immune deficiencies, neurological conditions, and other diseases.

MedinCell

MedinCell is a France-based pharmaceutical technology company developing long-acting injectable drug delivery systems. Its technology is designed to support sustained medication release, potentially reducing dosing frequency across different therapeutic applications.

Nanexa

Nanexa is a Swedish pharmaceutical technology company developing long-acting injectable medicines using its PharmaShell drug delivery platform. Its technology focuses on controlled drug release and reducing treatment frequency for patients requiring ongoing medication.

Peptilogics

Peptilogics is a biotechnology company developing peptide-based therapeutic technologies. Its research combines computational methods and drug development capabilities to design new medicines targeting important clinical needs.

SNIPRBIOME

SNIPRBIOME develops CRISPR-based technologies for precise targeting of microorganisms. Its biotechnology platform focuses on microbiome engineering and treatments targeting specific bacteria while preserving beneficial microbial populations.

Vaxxas

Vaxxas is an Australian medical technology company developing needle-free vaccine delivery systems. Its high-density microarray patch technology is designed to support vaccine administration through a small skin patch rather than conventional injections.

Alkem Laboratories

Alkem Laboratories is an Indian pharmaceutical company developing and manufacturing generic and specialty medicines. Its operations span pharmaceutical research, manufacturing, regulatory development, and commercial distribution across international healthcare markets.

Novotech

Novotech is a global clinical research organization supporting pharmaceutical and biotechnology companies. Its services cover clinical trial planning, execution, regulatory support, and research operations across multiple therapeutic areas.

FairJourney Biologics

FairJourney Biologics provides antibody discovery and engineering services for pharmaceutical and biotechnology companies. Its research capabilities support biologic drug development, antibody optimization, and therapeutic candidate selection.

Converge Bio

Converge Bio develops AI technology for biotechnology research and drug discovery. Its work focuses on applying advanced machine learning methods to biological data and helping pharmaceutical research teams identify promising therapeutic opportunities.

DEEPLIFE

DEEPLIFE develops AI-powered technologies for systems biology and drug discovery research. Its platform integrates biological data and computational modeling to support disease understanding, target discovery, and drug development.

OrbiMed

OrbiMed is a global healthcare investment firm operating venture capital, private equity, and other investment strategies. Its investments cover biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare services.

5AM Ventures

5AM Ventures is a life sciences venture capital firm investing in early-stage biotechnology businesses. Its portfolio focuses on therapeutics, drug discovery, and companies translating scientific research into new treatment approaches.

Mayo Clinic

Mayo Clinic is a US healthcare and medical research organization combining clinical care, scientific research, and medical education. Its innovation activities include clinical research, digital health, diagnostics, and collaborations with healthcare technology developers.

Ryvu Therapeutics

Ryvu Therapeutics is a Poland-based biotechnology company developing small-molecule cancer medicines. Its research focuses on oncology drug discovery and clinical development, including therapies targeting molecular mechanisms involved in cancer.

Healthcare Services and Industry Organizations at JPM Week 2027

FUJIFILM Biotechnologies

FUJIFILM Biotechnologies provides contract development and manufacturing services for biopharmaceutical companies. Its JPM Week 2027 event announcement invites partners to discuss manufacturing, process development, and biopharmaceutical production capabilities.

PwC

PwC provides consulting, transaction advisory, and other professional services to healthcare and life sciences organizations. During JPM Week 2027, it is hosting executive networking events and a collaboration hub for industry leaders and investors.

Sidley Austin

Sidley Austin is an international law firm advising healthcare and life sciences companies on financing, intellectual property, regulatory matters, and corporate transactions. Its 2027 JPM Week activities include meetings, networking events, and industry discussions.

Ice Miller

Ice Miller is a US law firm advising businesses across healthcare, life sciences, intellectual property, and corporate transactions. Its healthcare and life sciences team has announced meetings and networking events in San Francisco during the 2027 conference week.

ICR Healthcare

ICR Healthcare provides investor relations, corporate communications, and strategic advisory services to healthcare businesses. Its JPM Week 2027 program supports healthcare companies preparing investor meetings, business development conversations, and corporate announcements.

Biocom California

Biocom California is a life sciences industry association supporting biotechnology, pharmaceutical, and healthcare technology companies. Its JPM Week 2027 activities include networking receptions, partnering opportunities, and industry events connecting executives, investors, and innovators.

What Types of Companies Participate in JPM Healthcare Week 2027?

Why the J.P. Morgan Healthcare Conference 2027 Matters

The J.P. Morgan Healthcare Conference brings together pharmaceutical companies, biotechnology developers, healthcare technology businesses, and investors at the beginning of the year. Company presentations and industry meetings highlight clinical development, investment priorities, and emerging healthcare technologies.

The 2027 gathering creates opportunities for partnerships, licensing discussions, fundraising, and strategic collaborations across biotechnology, healthcare AI, pharmaceuticals, and medical technology.

For sales and business development teams, conference participation, funding announcements, clinical milestones, and expansion activity reveal healthcare companies exploring new partnerships, technologies, and services.

How We Built This List

Agent Jesse searched the live web for J.P. Morgan Healthcare Conference 2027 company activity, including conference announcements, investor presentations, corporate event calendars, partnering registrations, and JPM Week meeting programs.

The research brings together companies with announced conference participation and organizations independently participating in 2027 JPM Week activities, with each group identified by its event connection.

Last reviewed: November 5, 2026

Frequently Asked Questions

When and where is the J.P. Morgan Healthcare Conference 2027?

The 45th Annual J.P. Morgan Healthcare Conference takes place January 11–14, 2027, in San Francisco, California. The conference brings together pharmaceutical, biotechnology, medical technology, healthcare services, and investment organizations.

Which companies have announced participation in the J.P. Morgan Healthcare Conference 2027?

Immix Biopharma, Gubra, Genomics plc, Vicore Pharma, and Owkin have published 2027 conference participation or meeting information. Other healthcare companies, including Johnson & Johnson, Samsung Biologics, and Arcutis Biotherapeutics, are participating in separately organized JPM Week partnering activities.

Is the J.P. Morgan Healthcare Conference open to the public?

The J.P. Morgan Healthcare Conference is invitation-only, and invitations are non-transferable. Healthcare professionals, investors, and business development teams can also participate in independently organized JPM Week events, including BIO Partnering and other industry forums, subject to their registration requirements.

What is the difference between the J.P. Morgan Healthcare Conference and JPM Week?

The J.P. Morgan Healthcare Conference is the main investment symposium organized by J.P. Morgan. JPM Week refers to the broader collection of biotech partnering programs, investor meetings, industry forums, and networking events taking place in San Francisco around the conference.

How can I find biotech companies seeking investment or licensing partnerships during JPM Week 2027?

Track biotech funding announcements, clinical trial milestones, investor presentations, licensing deals, and partnering event participation. Agent Jesse searches the live web for these developments to identify biotechnology and pharmaceutical companies exploring investment, licensing, and strategic partnerships.

How can I identify decision-makers at companies participating in JPM Week 2027?

Relevant contacts include CEOs, business development executives, licensing directors, investor relations leaders, and research executives. Agent Jesse helps identify companies and decision-makers using event participation, funding announcements, clinical milestones, partnership activity, and expansion signals.

Find Your Next Prospects With Agent Jesse

Agent Jesse searches the live internet for healthcare and life sciences companies participating in industry events, developing new therapies, raising funding, announcing partnerships, hiring, adopting new technologies, and expanding operations.